Home » Topics » BioWorld

BioWorld
RSS

CLASS-ACTION SUIT AGAINST XYTRONYX

Feb. 6, 1992

APPLIED MICRO EXTENDS WARRANTS DEADLINE

Feb. 6, 1992

REGENERON ACQUIRES LICENSES FOR GMF

Feb. 6, 1992

ENCOURAGING DATA FROM IMMUNEX TRIALS

Feb. 6, 1992

VESTAR OFFERING RAISES $50 MILLION

Feb. 6, 1992

ECOSCIENCE RAISES $28.6 MILLION IN IPO

Feb. 6, 1992

METRA RAISES $6 MILLION IN FINANCING

Feb. 6, 1992

VCS OPTIMISTIC ABOUT 1992

Feb. 6, 1992

IMMUNOMEDICS GETS SBIR

Feb. 6, 1992

GENETIC REGIONS THAT CAUSE MD

Feb. 6, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...